Article

Flaxseed oil helps to prevent dry eye after LASIK

San Francisco-Flaxseed oil seems to be as effective as doxycycline in preventing the development of dry eye after LASIK. Colin C.K. Chan, MD, speculated that the reason may be due to its anti-inflammatory and lipid-modifying properties. He presented his ideas at the annual meeting of the American Society of Cataract and Refractive Surgery.

While the interest in the health-related properties of flaxseed oil has been escalating, Dr. Chan noted that no published studies have looked at the clinical use of flaxseed oil for dry eye.

"We had previously studied doxycycline and found that it was useful after LASIK for dry eye outcomes," he explained.

The main study outcome measure was dry eye grading on a scale of 2 to 5 using the KOWA DR-1 tear interferometer; using that scale, increased scores indicated increasing loss of the lipid layer. In addition, they graded the use of artificial tears on a scale ranging from 0 to 4, where 0 indicated no use and 4 indicated more than q.i.d. use. The measurements were done before LASIK and at 3 months after LASIK.

"There was no difference in the preoperative and postoperative grading of the tear interferometer between the flaxseed oil group and the doxycycline group," Dr. Chan said. "In addition, there was no substantial increase in the grading of dry eye 3 months after LASIK."

When investigators did subgroup analysis based on gender, age, and contact lens wear, the only relevant finding was that women had slightly higher postoperative dry eye gradings, as expected, he said.

There was also very little difference when they looked at the use of artificial tears in the two groups that was generally a score of 1, indicating occasional, once-daily use. They again found a very mild trend for women to use more artificial tears than men, according to Dr. Chan.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.